Search

everythinglearnresearchcommunity

for

Search:↓

Researchers developed promising agents for prostate cancer imaging, with the best one showing high potential for clinical use.

Tofacitinib may be an effective and safe treatment for hair loss in teenagers with alopecia areata.

The study found a specific peptide that helps detect TGase 3 activity in skin and hair follicles.

Terbinafine effectively stops fungal invasion of human keratin.

Centipeda minima and brevilin A protect skin cells from damage and aging.

The new composite scaffold may effectively treat chronic and deep wounds.

Loop diuretics may double bone loss in elderly men, finasteride lowers prostate cancer risk but may increase high-grade tumors, abarelix reduces testosterone quickly, and transdermal testosterone offers minimal sexual benefit for women.

Erlotinib can cause nonscarring hair loss and itchy skin.

FTase and GGTase-I are essential for skin keratinocyte health.

LY320236 is a strong blocker of two enzymes that change testosterone into dihydrotestosterone and might help treat conditions related to male hormones.

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.

Nanotechnology could improve scar treatment but needs more development.

Treg cells help repair and regenerate tissues by interacting with local cells.

TSC22D genes are key in metabolic diseases and cancer, offering potential as treatment targets.

Ritlecitinib may be more effective for severe alopecia areata than conventional treatments.

Small molecules KY19382 and KY19334 may help treat skin cancer by reducing CDK1 levels and blocking harmful cell signals.

Noggin promotes skin tumors by activating Wnt and Shh pathways.

Special gut cells help stem cells move to and fix injured areas by activating a specific signaling pathway.

Some drugs used to treat inflammation may cause hair loss.

Testosterone makes the connections in the uterus lining simpler and lowers certain protein levels, which might lead to infertility.

β-Catenin signaling is involved in brain cell growth after injury and could be a therapy target.

ZD1839 can cause skin issues like acne and hair changes.

TRPA1 and TRPV1 channels don't affect mechanotransduction in rat sinus hair follicles.

Tofacitinib helped some young children with severe hair loss grow their hair back without bad side effects.

MCTD should be considered in children with recurring muscle issues, lupus-like symptoms, and edema.

Tofacitinib is effective and safe for treating severe alopecia areata and related conditions.

Researchers developed a scaffold that releases a healing drug over time, improving wound healing and skin regeneration.

Netherton's syndrome is linked to high IgE levels and unique skin and hair symptoms, and may improve with ammonium lactate lotion and allergy management.

Leflunomide successfully treated a rare skin condition in a liver transplant patient.

HSA nanoparticles can improve tamoxifen delivery for breast cancer treatment, reducing side effects.